Your browser doesn't support javascript.
loading
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.
Zhang, Yumeng; Duncanson, Lauren; Brayer, Jason; Reu, Frederic; Hansen, Doris; Alsina, Melissa; Nishihori, Taiga; Ochoa-Bayona, Jose; Liu, Hien; Shain, Kenneth; Thompson, Zachary; Baz, Rachid; Blue, Brandon.
Afiliación
  • Zhang Y; Department of Hematology and Medical Oncology, University of South Florida/ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Duncanson L; Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Brayer J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Reu F; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Hansen D; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Alsina M; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Nishihori T; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Ochoa-Bayona J; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Liu H; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Shain K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Thompson Z; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Baz R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Blue B; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: Brandon.Blue@moffitt.org.
Clin Lymphoma Myeloma Leuk ; 22(8): e770-e776, 2022 08.
Article en En | MEDLINE | ID: mdl-35504808
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Amiloidosis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Amiloidosis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article